Characterization of the effects of methylmercury on Caenorhabditis elegans

Toxicology and Applied Pharmacology

Volumn 240, Issue 2, 2009, Pages 265-272

  Helmcke, Kirsten J ^a   Syversen, Tore ^b   Miller III, David M ^a   Aschner, Michael ^a,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Caenorhabditis elegans; Methylmercury

Indexed keywords

METHYLMERCURIC CHLORIDE;

ARTICLE; CAENORHABDITIS ELEGANS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEVELOPMENTAL DISORDER; LIFESPAN; MAMMAL CELL; MERCURIALISM; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NEUROTOXICITY; NONHUMAN; TOXICOKINETICS;

ANIMALS; CAENORHABDITIS ELEGANS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; ENVIRONMENTAL POLLUTANTS; LARVA; LONGEVITY; METHYLMERCURY COMPOUNDS; NERVOUS SYSTEM; NEUROGENESIS; NEURONS; PHARYNGEAL MUSCLES; REPRODUCTION; TIME FACTORS;

ANIMALIA; CAENORHABDITIS ELEGANS; MAMMALIA; NEMATODA;

EID: 70349232753     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.03.013     Document Type: Article

References (53)

1. Altun-Gultekin Z., Andachi Y., Tsalik E.L., Pilgrim D., Kohara Y., and Hobert O. A regulatory cascade of three homeobox genes, ceh-10, ttx-3 and ceh-23, controls cell fate specification of a defined interneuron class in C. elegans. Development 128 (2001) 1951-1969
2. Aschner M., Yao C.P., Allen J.W., and Tan K.H. Methylmercury alters glutamate transport in astrocytes. Neurochem. Int. 37 (2000) 199-206
3. Asikainen S., Vartiainen S., Lakso M., Nass R., and Wong G. Selective sensitivity of Caenorhabditis elegans neurons to RNA interference. Neuroreport 16 (2005) 1995-1999
4. Baraldi M., Zanoli P., Tascedda F., Blom J.M., and Brunello N. Cognitive deficits and changes in gene expression of NMDA receptors after prenatal methylmercury exposure. Environ. Health Perspect. 110 Suppl 5 (2002) 855-858
5. Bischof L.J., Huffman D.L., and Aroian R.V. Assays for toxicity studies in C. elegans with Bt crystal proteins. Methods Mol. Biol. 351 (2006) 139-154
6. Brenner S. The genetics of Caenorhabditis elegans. Genetics 77 (1974) 71-94
7. Brookes N. In vitro evidence for the role of glutamate in the CNS toxicity of mercury. Toxicology 76 (1992) 245-256
8. Bruinsma J.J., Schneider D.L., Davis D.E., and Kornfeld K. Identification of mutations in Caenorhabditis elegans that cause resistance to high levels of dietary zinc and analysis using a genomewide map of single nucleotide polymorphisms scored by pyrosequencing. Genetics 179 (2008) 811-828
9. Castoldi A.F., Coccini T., Ceccatelli S., and Manzo L. Neurotoxicity and molecular effects of methylmercury. Brain Res. Bull. 55 (2001) 197-203
10. Chase D.L., Pepper J.S., and Koelle M.R. Mechanism of extrasynaptic dopamine signaling in Caenorhabditis elegans. Nat. Neurosci. 7 (2004) 1096-1103
11. Clarkson T.W. The three modern faces of mercury. Environ. Health Perspect. 110 (2002) 11-23
12. Clarkson T.W., and Magos L. The toxicology of mercury and its chemical compounds. Crit. Rev. Toxicol. 36 (2006) 609-662
13. Coccini T., Randine G., Candura S.M., Nappi R.E., Prockop L.D., and Manzo L. Low-level exposure to methylmercury modifies muscarinic cholinergic receptor binding characteristics in rat brain and lymphocytes: physiologic implications and new opportunities in biologic monitoring. Environ. Health Perspect. 108 (2000) 29-33
14. Colavita A., and Tessier-Lavigne M. A Neurexin-related protein, BAM-2, terminates axonal branches in C. elegans. Science 302 (2003) 293-296
15. Cole R.D., Anderson G.L., and Williams P.L. The nematode Caenorhabditis elegans as a model of organophosphate-induced mammalian neurotoxicity. Toxicol. Appl. Pharmacol. 194 (2004) 248-256
16. consortium C.e.s. Genome sequence of the nematode C. elegans: a platform for investigating biology. Science 282 (1998) 2012-2018
17. Dock L., Rissanen R.L., and Vahter M. Demethylation and placental transfer of methyl mercury in the pregnant hamster. Toxicology 94 (1994) 131-142
18. Donohoe D.R., Aamodt E.J., Osborn E., and Dwyer D.S. Antipsychotic drugs disrupt normal development in Caenorhabditis elegans via additional mechanisms besides dopamine and serotonin receptors. Pharmacol. Res. 54 (2006) 361-372
19. Falluel-Morel A., Sokolowski K., Sisti H.M., Zhou X., Shors T.J., and Dicicco-Bloom E. Developmental mercury exposure elicits acute hippocampal cell death, reductions in neurogenesis, and severe learning deficits during puberty. J. Neurochem. 103 (2007) 1968-1981
20. Fitzgerald W.F., and Clarkson T.W. Mercury and monomethylmercury: present and future concerns. Environ. Health Perspect. 96 (1991) 159-166
21. Geier D.A., and Geier M.R. A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States. Neuro Endocrinol. Lett. 27 (2006) 401-413
22. Hope I.A. Background on Caenorhabditis elegans. In: Hope I.A. (Ed). C. elegans: A Practical Approach (1999), Oxford University Press, New York 1-15
23. Huang C., Xiong C., and Kornfeld K. Measurements of age-related changes of physiological processes that predict lifespan of Caenorhabditis elegans. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 8084-8089
24. Huang X., Cheng H.J., Tessier-Lavigne M., and Jin Y. MAX-1, a novel PH/MyTH4/FERM domain cytoplasmic protein implicated in netrin-mediated axon repulsion. Neuron 34 (2002) 563-576
25. Kerper L.E., Ballatori N., and Clarkson T.W. Methylmercury transport across the blood-brain barrier by an amino acid carrier. Am. J. Physiol. 262 (1992) R761-765
26. Kevorkian J., Cento D.P., Hyland J.R., Bagozzi W.M., and Van Hollebeke E. Mercury content of human tissues during the twentieth century. Am. J. Public Health 62 (1972) 504-513
27. Leung M.C., Williams P.L., Benedetto A., Au C., Helmcke K.J., Aschner M., and Meyer J.N. Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology. Toxicol. Sci. 106 (2008) 5-28
28. Mason R.P., Abbott M.L., Bodaly R.A., Bullock Jr. O.R., Driscoll C.T., Evers D., Lindberg S.E., Murray M., and Swain E.B. Monitoring the response to changing mercury deposition. Environ. Sci. Technol. 39 (2005) 14A-22A
29. Matthies D.S., Fleming P.A., Wilkes D.M., and Blakely R.D. The Caenorhabditis elegans choline transporter CHO-1 sustains acetylcholine synthesis and motor function in an activity-dependent manner. J. Neurosci. 26 (2006) 6200-6212
30. McIntire S.L., Reimer R.J., Schuske K., Edwards R.H., and Jorgensen E.M. Identification and characterization of the vesicular GABA transporter. Nature 389 (1997) 870-876
31. Nass R., Miller D.M., and Blakely R.D. C. elegans: a novel pharmacogenetic model to study Parkinson's disease. Parkinsonism. Relat. Disord. 7 (2001) 185-191
32. National Research Council, U. S. Scientific Frontiers in Developmental Toxicology and Risk Assessment (NRC, US) (2000), The National Academies Press, Washington, DC
33. Newland M.C., Reed M.N., LeBlanc A., and Donlin W.D. Brain and blood mercury and selenium after chronic and developmental exposure to methylmercury. Neurotoxicology 27 (2006) 710-720
34. Ong W.Y., and Farooqui A.A. Iron, neuroinflammation, and Alzheimer's disease. J. Alzheimers Dis. 8 (2005) 183-200 discussion 209-115
35. Parker S.K., Schwartz B., Todd J., and Pickering L.K. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics 114 (2004) 793-804
36. Rodier P.M., Aschner M., and Sager P.R. Mitotic arrest in the developing CNS after prenatal exposure to methylmercury. Neurobehav. Toxicol. Teratol. 6 (1984) 379-385
37. Roh J.Y., Jung I.H., Lee J.Y., and Choi J. Toxic effects of di(2-ethylhexyl)phthalate on mortality, growth, reproduction and stress-related gene expression in the soil nematode Caenorhabditis elegans. Toxicology 237 (2007) 126-133
38. Roh J.Y., Lee J., and Choi J. Assessment of stress-related gene expression in the heavy metal-exposed nematode Caenorhabditis elegans: a potential biomarker for metal-induced toxicity monitoring and environmental risk assessment. Environ. Toxicol. Chem. 25 (2006) 2946-2956
39. Rossi A.D., Ahlbom E., Ogren S.O., Nicotera P., and Ceccatelli S. Prenatal exposure to methylmercury alters locomotor activity of male but not female rats. Exp. Brain Res. 117 (1997) 428-436
40. Simmons-Willis T.A., Koh A.S., Clarkson T.W., and Ballatori N. Transport of a neurotoxicant by molecular mimicry: the methylmercury-l-cysteine complex is a substrate for human L-type large neutral amino acid transporter (LAT) 1 and LAT2. Biochem. J. 367 (2002) 239-246
41. Sobotka T.J., Cook M.P., and Brodie R.E. Effects of perinatal exposure to methyl mercury on functional brain development and neurochemistry. Biol. Psychiatry 8 (1974) 307-320
42. Stiernagle T. Maintenance of C. elegans. In: Hope I.A. (Ed). C. elegans: A Practical Approach (1999), Oxford University Press, New York
43. Stringari J., Nunes A.K., Franco J.L., Bohrer D., Garcia S.C., Dafre A.L., Milatovic D., Souza D.O., Rocha J.B., Aschner M., and Farina M. Prenatal methylmercury exposure hampers glutathione antioxidant system ontogenesis and causes long-lasting oxidative stress in the mouse brain. Toxicol. Appl. Pharmacol. 227 (2008) 147-154
44. Sulston J.E. Neuronal cell lineages in the nematode Caenorhabditis elegans. Cold Spring Harb. Symp. Quant. Biol. 48 Pt 2 (1983) 443-452
45. Sulston J.E., and Horvitz H.R. Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. Dev. Biol. 56 (1977) 110-156
46. Sulston J.E., Schierenberg E., White J.G., and Thomson J.N. The embryonic cell lineage of the nematode Caenorhabditis elegans. Dev. Biol. 100 (1983) 64-119
47. Sze J.Y., Victor M., Loer C., Shi Y., and Ruvkun G. Food and metabolic signalling defects in a Caenorhabditis elegans serotonin-synthesis mutant. Nature 403 (2000) 560-564
48. Thompson W.W., Price C., Goodson B., Shay D.K., Benson P., Hinrichsen V.L., Lewis E., Eriksen E., Ray P., Marcy S.M., Dunn J., Jackson L.A., Lieu T.A., Black S., Stewart G., Weintraub E.S., Davis R.L., and DeStefano F. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N. Engl. J. Med. 357 (2007) 1281-1292
49. Watson J.D., Wang S., Von Stetina S.E., Spencer W.C., Levy S., Dexheimer P.J., Kurn N., Heath J.D., and Miller III D.M. Complementary RNA amplification methods enhance microarray identification of transcripts expressed in the C. elegans nervous system. BMC Genomics 9 (2008) 84
50. White J.G., Southgate E., Thompson J.N., and Brenner S. The structure of the nervous system of the nematode Caenorhabditis elegans. Philos. Trans. R. Soc. Lond., B 314 (1986) 1-340
51. Williams P.L., and Dusenbery D.B. Using the nematode Caenorhabditis elegans to predict mammalian acute lethality to metallic salts. Toxicol. Ind. Health 4 (1988) 469-478
52. Wood W.B. Introduction to C. elegans Biology. In: Wood W.B., and Community of C. elegans Researchers (Eds). The Nematode Caenorhabditis elegans (1988), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
53. Yin Z., Jiang H., Syversen T., Rocha J.B., Farina M., and Aschner M. The methylmercury-l-cysteine conjugate is a substrate for the L-type large neutral amino acid transporter. J. Neurochem. 107 (2008) 1083-1090